Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001654954-19-012323
Filing Date
2019-11-04
Accepted
2019-11-04 15:43:59
Documents
16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT a06302019s-1a.htm S-1/A 2710583
2 OPINION ON LEGALITY exhibit-5opinion.htm EX-5 9279
3 CONSENTS OF EXPERTS AND COUNSEL exhibit23-1.htm EX-23 4496
4 IMAGE a06302019s-1002.jpg GRAPHIC 183571
5 IMAGE a06302019s-1003.jpg GRAPHIC 21545
6 IMAGE a06302019s-1004.jpg GRAPHIC 10497
7 IMAGE a06302019s-1005.jpg GRAPHIC 11230
8 IMAGE a06302019s-1006.jpg GRAPHIC 12128
9 IMAGE clonidineinhibits2.jpg GRAPHIC 28473
10 IMAGE exhibit-5opinion000.jpg GRAPHIC 8826
11 IMAGE incidenceofsom2.jpg GRAPHIC 15905
12 IMAGE logo.jpg GRAPHIC 10157
13 IMAGE medianduration2.jpg GRAPHIC 20582
14 IMAGE pancreatic2.jpg GRAPHIC 17319
15 IMAGE pipeline3.jpg GRAPHIC 42658
16 IMAGE plasma2.jpg GRAPHIC 32692
  Complete submission text file 0001654954-19-012323.txt   3299014
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-233303 | Film No.: 191189595
SIC: 2834 Pharmaceutical Preparations